Registered entities
Quark Pharmaceuticals, Inc.
Reg. No. 943192416Belgium
Innovation
75 patent families (45 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 10,821 times.
| Year | Filings |
|---|---|
| 2012 | 22 |
| 2013 | 27 |
| 2014 | 26 |
| 2015 | 21 |
| 2016 | 24 |
| 2017 | 20 |
| 2018 | 13 |
| 2019 | 7 |
| 2020 | 9 |
| 2021 | 6 |
Investor mix
3 investors on record; lead investors include SBI Investment.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 67% |
| Other / undisclosed | 1 | 33% |
